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Summary
The ubiquitin system plays an important role in trafficking of
signaling receptors from the plasma membrane to lysosomes.
Triad1 is a ubiquitin ligase that catalyzes the formation of
poly-ubiquitin chains linked via lysine-48 as well as lysine-63
residues. We show that depletion of Triad1 affects the sorting
of both growth hormone and epidermal growth factor.
Triad1-depleted cells accumulate both ligands in endosomes.
While fluid phase transport to the lysosomes is reduced in the
absence of Triad1, growth hormone receptor can recycle back
to the plasma membrane together with transferrin. Using
immune electron microscopy we show that Triad1 depletion
results in enlarged endosomes with enlarged and irregular
shaped intraluminal vesicles. The endosomes display
prominent clathrin coats and show increased levels of
growth hormone label. We conclude that Triad1 is required
for the proper function of multivesicular bodies.
 2012. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
In mammalian cells, the involvement of ubiquitination in
endosomal sorting has been well established (Clague and Urbe´,
2010; Sorkin and Goh, 2009; Stuffers et al., 2009a; Varghese et
al., 2008). Only in a few cases K63-linked ubiquitination was
indicated specifically in endocytosis (Paiva et al., 2009; Kramer
et al., 2010). Our model system, in which we study endocytosis
and endosomal sorting of the growth hormone receptor (GHR),
uses a K48 ubiquitin ligase for both endocytosis, and endosomal
sorting (van Kerkhof et al., 2007; van Kerkhof et al., 2011). To
learn more about the involvement of K63-linked ubiquitination,
we used a limited library of silencing RNAs that specifically
target ubiquitin ligases, known to be involved in K63 linkage
assembly. From this screen TRIAD1 (two RING [really
interesting new gene] fingers and DRIL [double RING finger
linked] 1) emerged as being required for the degradation of both
growth hormone (GH) and epidermal growth factor (EGF).
TRIAD domain-containing ubiquitin ligases contain a
cysteine-rich DRIL/IBR domain that is flanked by two RING
fingers. In several TRIAD proteins the N-terminal RING finger
specifically binds K48 chain E2 conjugating enzymes, while the
C-terminal RING finger binds the K63 E2 enzyme, Ubc13. The
best studied TRIAD proteins are Parkin, Hoil-1, Hoip, Dorfin and
Triad1 (Wenzel et al., 2011). TRIAD proteins regulate diverse
biological processes (Huang et al., 2006; Ishigaki et al., 2007;
Tokunaga et al., 2009). Parkin, the best studied TRIAD protein
(reviewed by Chin et al., 2010), has been reported to regulate
K48-dependent proteasomal degradation of several substrates (7)
(Narendra et al., 2008). Triad1 got attention for its role in
myeloid cell proliferation and by regulating the levels of the
transcription factor Gfi-1 (Marteijn et al., 2007; Wang et al.,
2011). For Triad1, direct interactions of the E2 enzymes UbcH7
and Ubc13 with RING1 and RING2, respectively, have been
shown (Marteijn et al., 2009). Although the conserved
combination of RING1 and RING2 together with the DRIL/
IBR domain suggest a close collaboration between the K48 and
K63 ubiquitin systems, its conservation remains elusive.
In the endosomal sorting system, both K63- and K48-linked
ubiquitin play a role. The endosomal system collects membranes
and proteins from the plasma membrane and the trans-Golgi
network (TGN), and sorts them either back to the plasma
membrane (default route) and to the TGN or, via multivesicular
bodies (MVB) to the lysosome. Membrane coats of different
compositions including clathrin collect the cargo and shape the
membrane. Recently, Golgi localized c-ear containing ARF
binding adapter proteins (GGA) were attributed a role trapping
the K63 ubiquitinated cargo from early endosome to the MVB
(Lauwers et al., 2009). Rabs, a family of small GTPases, identify
the formed vesicles and control their budding, uncoating, motility
and fusion (reviewed by Markgraf et al., 2007; Stenmark, 2009).
This is accomplished by recruiting tethering factors, sorting
adapters, kinases, phosphatases and motor adapters. ESCRT
(endosomal sorting complex required for transport) complexes
receive the ubiquitinated cargo from coat proteins and GGAs and
facilitate the formation of the intraluminal vesicles (ILV)
containing the cargo. The Vps-C complexes, homotypic fusion
and vacuole protein sorting (HOPS) and CORVET, convert Rab5
into Rab7-positive endosomes, thus creating mature MVBs (Rink
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et al., 2005; Woodman and Futter, 2008), tether membranes,
guide SNARE assembly to drive membrane fusion (Richardson et
al., 2004), and possibly act as ubiquitin ligases (Nickerson et al.,
2009).
Since the dynamics of (de)ubiquitination plays a pivotal role in
endosomal trafficking, ubiquitinating enzymes are expected to be
part of the machinery. In particular, a role for c-Cbl, required
both at the plasma membrane and in endosomes, has been
extensively studied (Sorkin and Goh, 2009). Related to
endosomal sorting, ESCRT0 contains K48 and K63-specific
ubiquitin proteases, while components of HOPS, Vps-C and
ESCRTs contain RING type E3 ligases. MVB sorting of most
yeast membrane proteins depends on their ubiquitination by
Rsp5p (Blondel et al., 2004; Dunn et al., 2004; Hettema et al.,
2004; Katzmann et al., 2004; Morvan et al., 2004). In mammals,
these roles are performed by its ortholog, the Nedd4 family, or
SCF(b-transducing repeat-containing protein), and members of
the MARCH family (Blot et al., 2004; Fukuda et al., 2006;
Morokuma et al., 2007; Nakamura et al., 2005; Polo et al., 2002;
van Kerkhof et al., 2007; van Kerkhof et al., 2011). In this study,
we identified Triad1 as an E3 involved in endosomal trafficking.
Depletion of Triad1 alters the fate of two different prototypic
receptors, epidermal growth factor receptor (EGFR) and GHR.
Both receptors accumulate at endosomes and remain in the
recycling pathway. In addition, accumulation in lysosomes of the
fluid phase marker, dextran, is diminished. In the absence of
Triad1, the morphology of the sorting endosome and MVB
changes, indicating a role in the sorting machinery of both
membrane proteins and of fluid phase content.
Results
Triad1 affects post-endocytic trafficking of GHR
Triad1 is a ubiquitin ligase (E3) that binds both K48 and K63-
specific ubiquitin E2 enzymes (Marteijn et al., 2009). Both types
of chains are involved in receptor internalization. Therefore, we
studied the role of Triad1 in protein sorting using different
substrates to discriminate between endosomal sorting (EGF, GH),
recycling between plasma membrane and endosomes (transferrin
[Tf]) and fluid phase transport to lysosomes (dextran). U2OS
cells, expressing both GHR and EGFR, were treated with a
validated Triad1 siRNA for three days and analyzed for effects
on uptake and distribution. A 30-min uptake of cy3-GH and
Alexa 488-EGF in mock depleted (control) cells showed GH and
EGF internalization mainly in endosomal vacuoles (Fig. 1A,
lower panel). At this time point, lysosomal degradation of GH
starts as was previously shown (van Kerkhof and Strous, 2001).
In Triad1-depleted cells an increase in total label was observed
and the fluorescence pattern changed from small dispersed
punctae to larger and fewer spots (Fig. 1A, upper panel). Cy3-
GH could clearly be identified at the plasma membrane (Fig. 1A–
D, compare upper panels). Furthermore, large-sized vesicles,
positive for both cy3-GH and Alexa 488-EGF, were observed.
Closer examination of these vesicles revealed that they were
clustered in groups, larger than in untreated cells (Fig. 1A,
zoom). The overall subcellular localization of the vesicles did not
seem to be altered compared to control cells. Two other validated
siRNAs were equally effective in generating these phenotypes
(data not shown). The data suggest that Triad1 depletion results
in intracellular accumulation of both GH and EGF. The increase
of cy3-GH at the plasma membrane indicates that Triad1
silencing might result in recycling.
Once established that Triad1-depletion had similar effects on
both EGF and GH trafficking we used the GH system to
investigate the nature of the vesicles in more detail. After a 30-
min uptake of cy3-GH followed by 30 min of chase in the
presence of Alexa 488-Tf, in control cells, Tf appeared in peri-
nuclear, recycling endosomes, separated from cy3-GH (Fig. 1B).
These endosomes were previously described as the recycling
compartment that contains tubulovesicular structures and
recycles EGF and Tf with slow kinetics (Sorkin et al., 1991;
van Dam et al., 2002; van Kerkhof et al., 2011). In cells depleted
for Triad1, the majority of cy3-GH co-localized with Tf in
enlarged vesicular structures, possibly early endosomes.
Normally, 80% of Tf receptors reside within early endosomes
and recycle continuously between the plasma membrane and
endosomes (Ciechanover et al., 1983). As we did neither observe
a redistribution of Tf nor accumulation at the plasma membrane,
we conclude that Triad1 does not affect the trafficking of Tf.
The accumulation of GHR in vesicles together with Tf in
Triad1-depleted cells suggested that the receptors were not sorted
to the lysosome anymore. To investigate this further, U2OS cells
were incubated for 30 min with cy3-GH followed by a 15 min
chase in absence of cy3-GH to allow GH to reach the late
endosomes and lysosomes. After fixation, cells were
permeabilized and stained with anti-LAMP-1 antibodies. In
control cells, cy3-GH and LAMP-1 co-localized, indicating that
GHR had reached the LAMP-1 positive late endosomes and
lysosomes within 45 min (Fig. 1C, lower panel). In Triad1-
depleted cells, cy3-GH and LAMP-1 did not co-localize,
suggesting that GHR did not reach LAMP-1 positive
compartments within this time frame. Therefore, we
investigated whether a fluid phase endocytic marker was still
able to reach LAMP-1-positive compartments. Cells were
incubated with Alexa-647 dextran (10.000 Mr) for 2 h,
followed by a 30-min uptake of cy3-GH, which was chased
again for 15 min. As expected, in control cells, almost all dextran
(,90%) co-localized within LAMP-1-positive compartments,
part of which could also be found in structures positive for cy3-
GH (Fig. 1D, lower panel). In Triad1-depleted cells, dextran still
co-localized with LAMP-1, but as observed in Fig. 1C, cy3-GH
did not co-localize. Strikingly, the total amount of dextran
present in Triad1-depleted cells was consistently lower. In
supplementary material Fig. S3C, we repeated the experiment
with a slightly different uptake protocol, directly comparing the
uptake capacity via the GHR for 30 min with a 2 h accumulation
of dextran. Together, the results show that fluid phase transport to
lysosomes is affected by Triad1 depletion.
As both EGF and GH remain bound to their receptors until
they arrive in the lysosomes, we conclude that both GH and EGF
receptors take identical routes toward lysosomes (Fig. 1A). These
data strongly suggest that in the absence of Triad1 both receptors
accumulate in (recycling) endosomes together with the Tf
receptor, and that fluid phase content, trafficking to LAMP-1-
positive lysosomes, is impaired.
Triad1 acts at an endosomal compartment
Since uptake experiments with fluorescent ligands suggest that
GHR transport to lysosomes is impaired, the effect of Triad1
depletion was evaluated biochemically. Quantitation of the
western blot shown in Fig. 2A revealed a ,4 times increase in
the amount of GHR compared to cells treated with control
siRNA. This suggests that the GHR degradation was strongly
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Fig. 1. Effect of Triad1 depletion on EGF, GH, Tf and
dextran. (A) U2OS cells expressing GHR and EGFR were
depleted for Triad1, incubated with cy3-GH (red) and
Alexa-488 EGF (green) for 30 min, and the labels were
visualized by confocal microscopy. (B) U2OS cells
expressing GHR were depleted as in A and incubated with
cy3-GH (red) for 30 min and chased for 30 min in presence
of Alexa-488 Tf (green). (C) Cells as in B were incubated
with cy3-GH (red) for 30 min, chased for 15 min and fixed.
Permeabilized cells were incubated with anti-LAMP-1
antibodies and Alexa 488 (green), goat-anti-mouse
antibodies. (D) Cells as in B were incubated with 647-
dextran (blue) for 2 h, chased with cy3-GH (red) for
30 min, followed by a second chase without any fluorescent
probe, stained with LAMP-1 antibodies (green) as in C. At
the left side low resolution overviews are presented, at the
right side phenotypic parts (boxed) of cells are enlarged to
demonstrate the differences between the silencing effects of
Triad1. Scale bars represent 10 mm. All data in this figure
are representatives of three independent experiments.
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impeded. To investigate a possible effect on biosynthesis we
performed pulse-chase labeling. Control and Triad1-depleted cells
were pulse-labeled with [35S]methionine/cysteine and chased for
2 h (Fig. 2B). Quantification, corrected for differences in labeling
efficiencies (see Materials and Methods), showed that in Triad1-
depleted cells ,20% less GHR was synthesized in 15 min
compared to control cells. This indicates that GHR synthesis did
not increase after depletion of Triad1. After a 2-h chase period
,50% of GHR remained intact in control cells, whereas ,65%
remained in Triad1-depleted cells. Together, these data confirm
that not synthesis of GHR is increased but its half-life is extended
upon Triad1 depletion.
To investigate this further, we performed uptake experiments
using 125I-GH. Control, Triad1-, and TrCP-depleted U2OS cells
were incubated for 2 h with 125I-GH on ice and subsequently
chased at 37 C˚ for 45 min. As expected, typically, the amount of
initially bound GH was about 4.5 times higher in Triad1-depleted
cells as compared to control cells (data not shown). After a 45-
min chase, a slight increase of surface-bound GH was found in
both Triad1 (p#0.21) and TrCP (p#0.093) depleted cells as
compared to control depleted cells (Fig. 2C, left panel).
Quantification of intracellular 125I-GH confirmed that Triad1-
depleted cells accumulated significantly more (26%) GH
compared to control (6%, p50.05), and TrCP-depleted cells
(9%, p50.06), respectively (Fig. 2C, middle panel) (Fig. 1;
supplementary material Fig. S3). In control cells, about 42% of
the originally bound 125I-GH was degraded and secreted as free
iodide within 2 h (Fig. 2C, right panel). In Triad1-depleted cells
significantly less GH (12%, p50.004) was degraded, indicating
that degradation was strongly inhibited. As shown before,
depletion of TrCP, the ubiquitin ligase required for GHR
endocytosis, reduced the degradation to 19% (p50.007) (van
Kerkhof et al., 2011).
The relative large amount of intracellular GH in Triad1-
depleted cells, compared to TrCP-depleted cells, combined with
an unaffected synthesis rate of GHR, suggested that GHR was
forced to recycle between plasma membrane and endosomes.
This hypothesis requires that Triad1 is not involved in GHR
endocytosis. To test this we performed a kinetic experiment in
which 125I-GH was chased for short time periods (up to 15 min),
a time frame in which only GH uptake occurs with little to no
recycling (van Kerkhof et al., 2000). About 50% of the cells
treated with siRNAs against TrCP or Triad1 showed the
described phenotypes (supplementary material Fig. S3D).
Under these conditions, GH uptake rates of Triad1-depleted
and control cells were similar (p50.28). Silencing of TrCP
resulted in a decreasing uptake rate within this short time frame,
yielding significantly less intracellular GH (10%, p50.009)
compared to control cells (Fig. 2D). Combined with the observed
intracellular accumulation, these data strongly suggest that the
increase in GHR at the plasma membrane is due to increased
recycling rather than decreased endocytosis. We conclude that,
following Triad1 silencing, endocytosed GHR is diverted from
the route to lysosomes into the recycling pathway. This is
supported by the co-localization of GHR with Tf, which implies
that both GHR and EGFR accumulate in a recycling
compartment.
Triad1 depletion accumulates GHR in endosomal vacuoles
Next, we analyzed cells showing the distinctive knockdown
phenotype by correlative light-electron microscopy (van
Rijnsoever et al., 2008). Control or Triad1-depleted U2OS cells
were incubated for 30 min with biotinylated GH and processed
for correlative microscopy. By light microscopy we selected cells
showing a clustered localization of internalized GH-biotin in
Triad1-depleted cells (Fig. 3A,D) and by correlative microscopy
(supplementary material Fig. S2; Fig. 3B,C,E) we identified
these spots as endosomes with many ILVs and prominent flat bi-
layered clathrin coats, characteristic for early endosomes. The
endosomes contained high levels of GH-biotin labeling that was
associated with both the endosomal limiting membrane and the
ILVs. In some cells, multiple endosomes were clustered
(Fig. 3F). However, the endosomes appeared not to be tethered
together like has been observed in USP8 depleted cells (Row et
al., 2006). The endosomal vacuoles were surrounded by small
vesicular and tubular membrane profiles also positive for GH-
biotin (Fig. 3F). This localization differed from control cells, in
which endosomes contained less GH-biotin label and were found,
dispersed in the cytoplasm (supplementary material Fig. S2).
Furthermore, in Triad1-depleted cells, the endosomes contained a
Fig. 2. Effect of Triad1 depletion on GHR synthesis, endocytosis, and
degradation. (A) Western blot of GHR, Triad1, and actin of U2OS lysates of
cells treated with siRNA for Triad1 or control siRNA. In addition to the
increased signal at the mature 130-kDa GHR band, the faster migrating band is
due to intermediate degradation products. Both bands were taken to calculate
the increase due to Triad1 depletion. m, mature GHR (130 kDa). Gene
silencing of endogenous Triad1 is visualized in the middle panel, representative
for the three siRNAs used in this study. (B) GHR-expressing U2OS cells
depleted as in A were labeled with [35S]methionine for 15 min at 37 C˚ and the
radioactivity was chased for 2 h. GHR was immunoprecipitated with anti-GHR
antibody (anti-T). p, precursor GHR (110 kDa); m, mature GHR (130 kDa);
Triad1 (60 kDa). In the lower part total radioactivity was visualized. (C) GHR
expressing U2OS cells, depleted as in A, were incubated with 180 ng/ml 125I-
GH on ice for 2 h, and the cells were chased for 0 and 45 min. Surface-bound,
internalized, and TCA-soluble label was expressed as percentage of total
radioactivity. (D) Experiment as in C using a shorter time frame to measure
only uptake kinetics. Intracellular and plasma membrane radioactivity were
quantified. Error bars indicate 6 1 S.E.M. All data in this figure are
representative of three independent experiments. The silencing efficiency as
controlled by western blot was less than 30%. * (p,0.05) and ** (p,0.01)
indicate significant differences.
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more extended coat compared to endosomes from control cells.
Together, these data show that depletion of Triad1 causes
accumulation of endosomal vacuoles with surrounding vesicles
and increases the number of ILVs.
Discussion
In this study we added yet another ubiquitin ligase to the growing
list of ubiquitination enzymes involved in membrane traffic. Our
confocal studies show that in Triad1-depleted cells GHR and
EGFR accumulate in intracellular vesicles and at the plasma
membrane. The intracellular vesicles are most probably early
endosomes since Tf co-localized with GH in these vesicles. The
confocal studies were confirmed by biochemical experiments
that showed that lysosomal degradation of 125I-GH was indeed
inhibited in Triad1 depleted cells. Electron microscopy studies of
the endosomal sorting system showed that Triad1 depletion
results in enlarged sorting endosomes with elongated protein
coats. While the integral membrane proteins (the two receptors
including their cargo) accumulated in MVBs as well as in the
recycling pathway, limited amounts of dextran could still reach
the LAMP-1 positive compartments. Previously, we have shown
that proteasomal inhibitors block the transport of GH at the level
of MVBs, while dissociating ligands as well as the fluid phase
marker, colloidal-gold-labeled albumin, had free access to
lysosomes (van Kerkhof et al., 2001). Formation of MVBs is
still possible after depletion of ESCRT proteins (Stuffers et al.,
2009b). Also under these conditions, EGFR could not progress to
the lysosome, and the authors suggested a role for LBPA in the
formation of the ESCRT-independent ILVs (Matsuo et al., 2004;
Raiborg et al., 2008; Stuffers et al., 2009b). Assuming that
growth factor and cytokine receptors use MVBs to travel to the
lysosomes and take fluid phase content along, Triad1 is most
likely a controlling factor in membrane trafficking between the
recycling endosome and the lysosome. In its absence selection of
membrane proteins at the MVB is inhibited as well as the
throughput of endocytosed soluble content.
There are several reasons to assume that Triad1 works on the
sorting machinery. First, Triad1 affects the sorting of both EGFR
and GHR. The selection mechanisms of these receptors differ,
both at the plasma membrane and in endosomes (TrCP for GHR
via the ubiquitin-dependent endocytosis motif and c-Cbl for
EGFR via phosphorylated Y1045 residue) (Govers et al., 1999;
Levkowitz et al., 1999). At the level of MVBs Hrs seems to be
involved in EGFR sorting, while Tsg101 is required for directing
the GHR towards MVBs (van Kerkhof et al., 2011). Second,
Triad1 depletion results in altered morphology of the endosomal
system. Triad1 seems to affect either the selection of integral
membrane proteins into MVBs (forcing them into a recycling
mode back to the plasma membrane) or the disassembly of the
sorting machinery, causing blockage of both membrane and
content cargo to exit the MVB stage or fusion with the next
category of lysosome-bound vesicles. The latter possibility is
most relevant, as it would explain the electron microscopic
observations: onset and fission of ILVs is unaffected and the
blockage would induce accumulation of traffic to and from
MVBs (recycling), ultimately resulting in GH stocked ILVs,
leaving the majority of GH in the recycling pathway. The effect
of Triad1 differs from the phenotypic effects of overexpressing
the ATPase-deficient mutant hVPS4EQ (Sachse et al., 2004)
under the latter conditions being less ILVs present. As VPS4
catalyzes ESCRT-III disassembly (Babst et al., 1998) and ILVs
are still being formed including their cargo, it would imply that
Triad1 acts in a later stage. An explanation for the increased size
and irregular shape of both MVBs and ILVs would be the
accumulation of unprocessed cargo that causes a shortage of both
membrane and (ESCRT) factors.
The question how Triad1 is involved in endosomal transport
remains open. Until now, endogenous substrates that are
modified with ubiquitin by Triad1 are unknown (Marteijn et
al., 2009). Given its localization in both cytosol and nucleus with
no enrichment at the endosomal system, it is likely that this E3
ligase acts in multiple mechanisms (supplementary material Fig.
S3A). Triad1 binds the transcription factors Gfi1 and 1B
(Marteijn et al., 2007). Counter intuitively, forced Triad1
expression inhibits the ubiquitination and proteasomal
Fig. 3. Ultrastructural characterization of the Triad1-depleted phenotype.
(A,D) U2OS cells were silenced for Triad1 for 3 days, incubated for 30 min
with GH-biotin, fixed and prepared for ultrathin cryosectioning and labeling
with anti-biotin. The anti-biotin antibody was subsequently marked with both
Alexa488 and PAG10 to allow correlative microscopy. The large fluorescent
spots identified in A (1 and 2) and D (square) are typically induced by Triad
knockdown. Bars: 10 mm. (B,C) Applying correlative immune electron
microscopy (for intermediate step in the procedure, see supplementary material
Fig. S1), the fluorescent spots 1 and 2 shown in A were identified as endosomal
vacuoles (E) with many ILVs, prominent bi-layered clathrin coats (arrows) and
heavy labeling for GH-biotin (PAG10). (E) The bright fluorescent spot in D
was found to consist of two closely apposed endosomes. (F) Example of a large
cluster of endosomes induced by Triad knockdown. The endosomes are
surrounded by many vesicular and tubular membrane profiles. Bars: B, 600;
C, 500; E, 800; F, 800 nm.
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degradation of Gfi1, whereas Triad1 knockdown results in
increased ubiquitination. The inhibition of ubiquitination occurs
also by an UbcH7 binding-defective Triad1 mutant as well as in
the presence of proteasome inhibitors. This suggests that the
inhibition of ubiquitination is not caused by the ubiquitination
and proteasomal degradation of E3 ligases that mark Gfi1 with
ubiquitin for proteasomal degradation. Thus, Triad1 may rather
recruit a DUB to Gfi1 that may de-ubiquitinate the latter. The
decrease in ubiquitination of binding partners is similar as
reported for the TRIAD ubiquitin ligase Hoil-1 that inhibits
ubiquitination of the transcription factor Dax-1 (Ehrlund et al.,
2009) and the suppressor of cytokine signaling SOCS6 (Bayle et
al., 2006). In light of these observations, Triad1 might control
traffic through the endosomal compartment by ubiquitinating
proteins implicated in MVB formation and fusion with
lysosomes. Thus, a functional link between Triad1 and for
instance the HOPS complex that is involved in lysosomal fusion
events would be an obvious possibility, where Triad1 might
cooperate with other RING proteins present in the HOPS
complex such as Vps18 (Seals et al., 2000). In such scenario,
less Triad1 activity would translate in increased signaling activity
of growth factor receptors. This would be in line with a
controlling function of the endocytic machinery in balancing the
degradation of a variety of cytokine growth factor and tyrosine
kinase receptors involved in migration, growth, survival,
oncogenicity and immunity by endosome-ancillary factors like
Cbl, Nedd4, Tsg101, and Triad1 (reviewed by Mosesson et al.,
2008). Whether overexpression of Triad1, as shown previously to
inhibit colony formation by myeloid progenitor cells, is directly
regulated via Gfi1 ubiquitination or indirectly via cytokine
receptor degradation remains an intriguing question.
Materials and Methods
Materials, antibodies and DNA constructs
The rabbit wild type and mutant GHR cDNAs in pcDNA3 have been described
before (Govers et al., 1999). A plasmid expressing EGFR was obtained from Dr.
Paul van Bergen en Henegouwen, Utrecht University. Protein A-beads were from
Repligen. Antibody anti-GHR (T) was raised in rabbits against the cytoplasmic
sequence between amino acids 271-381, as previously described (Strous et al.,
1996). An antibody against Triad1 was generated by immunizing rabbits with a C-
terminal peptide of the human Triad1 protein (NP_006312, amino acids 459-472,
WKVERADSYDRGDL), coupled to the carrier protein LPH (C-WKV). After six
immunization rounds with this peptide, antisera were collected and tested for
specificity on cell lysates of Triad1 overexpressing and depleted cells. Antibody
against the extracellular domain of the GHR (Mab5) was from Santa Cruz
Biotechnology, Inc., goat anti-mouse IgG Alexa488 from Molecular Probes, and
goat anti- rabbit IgG IRDye800 from Rockland Immunochemicals Inc,
Gilbertsville (PA). Alexa488-Tf was from Molecular Probes, EGF-Alexa Fluor
488 streptavidin from Invitrogen, mouse monoclonal anti-FLAG (M2) from
Sigma, and mouse monoclonal anti LAMP-1 antibody (CD107A) from BD
Biopharming. Immobilized streptavidin was from Pierce, glutathione-sepharose
from Amersham Biosciences, and Ni-NTA agarose from Qiagen. Culture media,
fetal calf serum (FCS), L-glutamine, and antibiotics for tissue culture were
purchased from Invitrogen.
Cell culture
Human osteosarcoma (U2OS) cells expressing the wild type and mutant GHR or
EGFR were grown in DMEM (Invitrogen) with 10% FCS, 100 units/ml penicillin,
0.1 mg/ml streptomycin, supplemented with 150 mg/ml hygromycine (GHR) and/
or 125 mg/ml zeocin (EGFR). Cells were cultured at 37 C˚ with 5% CO2.
Transfections
To silence the expression of Triad1 cells were transfected with 50 nM of 3
validated small interfering RNAs directed against Triad1 (ARIH2 Ambion 135640,
GCCTAATCCATCAAAACAT); UUGUGAGGAAGAGGAAGAA (Marteijn et al.,
2007), and UUCUUCCUCUUCCUCACAA (Applied Biosystems Europe BV) using
Dharmafect (Thermo Fisher Scientific). As all three RNAs showed identical
phenotypes, the first was used in all studies. Three days after transfection, cells were
used for experiments. Control cells were transfected with siRNA Control#1 (Ambion,
AM4636). To control the efficiency of the gene silencing, antibodies against the
Triad1 protein were used. Western blots were analyzed using an Odyssey infrared
imaging system (Li-Cor Biosciences, Lincoln, Nebraska).
Pulse-chase analysis, immunoprecipitation, and SDS-PAGE
For metabolic labeling experiments, cells were grown in RPMI 1640 medium
(BioWhittaker) without methionine and cysteine at 37 C˚ for 2 h. The cells were
labeled with 250 mCi of 35S-labeled Redivue Promix (a mixture of L-
[35S]methionine and L-[35S]cysteine) (Amersham Biosciences) per 107 cells in
RPMI 1640 medium. To chase, radioactive medium was replaced with medium
supplemented with 1 mM methionine/cysteine (Sigma). The cells were lysed in
1% Triton X100, 1 mM EDTA in PBS in presence of protease inhibitors as
described (van Kerkhof et al., 2000). After centrifugation immunoprecipitation
were performed in lysates diluted 1:1 with Immunomix (1% Triton X100, 1% SDS,
0.5% DOC, 1% BSA, 1 mM EDTA in PBS). Immunoprecipitation was performed
at 4 C˚ for 2 h using specific antiserum and protein A-Sepharose beads (Amersham
Biosciences). The beads were washed 3 times with immunomix and 3 times with
10-fold diluted PBS. The washed beads were boiled in Laemmli sample buffer for
5–10 min. A fraction of labeled total cell lysates was loaded on gel to correct for
differences in cell number and labeling efficiency. Samples were loaded onto SDS-
polyacrylamide gels and exposed to a storage phosphor imaging screen, which was
scanned in a Personal Molecular Imager FX and analyzed with Quantity One
software (Bio-Rad, Veenendaal, The Netherlands). Quantified data were corrected
by dividing the specific signal by the signal obtained from total cell lysates.
Ligand binding, internalization, and degradation
125I-human GH was prepared with the use of chloramine T (Strous et al., 1996) and
purified over a 500 ml Zeba spin column (Pierce, Thermoscientific). For
internalization studies, cells were grown in 12-well plates, treated with siRNAs
as described above, washed with MEM supplemented with 20 mM, HEPES pH 7.4
and 0.1% BSA, and incubated in a water bath. 125I-GH (180 ng/ml) was bound on
ice for 2 h, the cells were washed free of unbound ligand, and incubated for 0–
45 min at 37 C˚. Membrane-associated ligand was removed by acid wash (0.15 M
NaCl, 50 mM glycine, 0.1% BSA, pH 2.5) on ice. Internalized ligand was
determined by measuring the radioactivity after solubilization of the acid-treated
cells in 1 N NaOH in a LKB gamma counter. For degradation studies, at the
indicated times, the medium was collected and precipitated with 1 volume of ice-
cold 20% TCA for 10 min on ice. Acid-soluble radioactivity was determined in the
supernatant after centrifugation and was used as a measurement for degraded
ligand. Membrane-associated and internalized ligands were determined as
described above. Background was determined by subtracting initial intracellular
and TCA precipitated medium from all other time points.
Immune fluorescence microscopy
Cy3-GH was prepared using a Fluorolink-Cy3 label kit according to the supplier’s
instructions (Amersham Biosciences). Cells, grown on coverslips, were incubated
with Cy3-GH (1 mg/ml), Alexa488-labeled Tf (25 mg/ml), or EGF Alexafluor 488
streptavidin (100 ng/ml). Cells were washed with PBS to remove unbound label
and fixed for 2 h in 3% paraformaldehyde in phosphate buffer, pH 7.4. After
fixation, the cells were permeabilized in 0.2% Triton for 5 min and the coverslips
were incubated with anti-Lamp1 and fluorescently labeled secondary antibodies.
The coverslips were embedded in Mowiol, and visualization was performed using
a Zeiss Ultraview system.
Correlative light electron microscopy (CLEM)
U2OS cells, expressing both GHR and EGFR were incubated with biotinylated GH
for 30 min. Cells were fixed by adding freshly prepared 4% formaldehyde in 0.1 M
phosphate buffer pH 7.4 to an equal volume of culture medium for 10 min,
followed by post-fixation in 4% formaldehyde in 0.1 M phosphate buffer pH 7.4.
Cells were stored until further processing in 1% formaldehyde at 4 C˚. Processing
of cells for ultrathin cryosectioning was done as described (Slot and Geuze, 2007).
In brief, fixed cells were washed with 0.05 M glycine in PBS, scraped gently from
the dish in PBS containing 1% gelatin, resuspended and pelleted in 12% gelatin in
PBS, 37 C˚. The cell pellet was solidified on ice and cut into small blocks. For
cryoprotection, blocks were infiltrated overnight with 2.3 M sucrose at 4 C˚ and
afterwards mounted on aluminum pins and frozen in liquid nitrogen. To pick up
ultrathin (65 nm) cryosections a 1:1 mixture of 2.3 M sucrose and 1.8%
methylcellulose was used. Sections were placed on 75 mesh hexagonal cupper
findergrids (Agar scientific), which contained a formvar film and were carbon
coated.
Correlative microscopy of fluorescence- and immunogold-labeled ultrathin
cryosections was done essentially as described (Vicidomini et al., 2008) with a few
adaptations. Briefly, grids were incubated on 2% gelatin in PBS for 20 min at
37 C˚, then incubated with rabbit anti-Biotin (Rockland) in 1% BSA in PBS for
45 min, rinsed in 0.1% BSA in PBS, and incubated with goat anti-rabbit Alexa
488-conjugated antibodies (Molecular Probes) for 45 min. Grids were rinsed
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followed by incubation with protein A conjugated to 10 nanometer gold particles
(PAG10; Department of Cell Biology, UMC, Utrecht) for 20 min, fixed for 5 min
with 1% glutaraldehyde in PBS, rinsed in PBS and incubated in Hoechst 1 mg/ml
in PBS. For fluorescence, grids were mounted between a microscope slide and
coverslip with 50% glycerol and imaged in a Deltavision RT microscope (Applied
Precision, Issaquah WA) using an EMCCD camera. For subsequent transmission
electron microscopy, grids were unmounted, washed in water, incubated for 5 min
in 2% uranyl acetate and 0.15 M oxalic acid and subsequently for 5 min in 0.4%
uranyl acetate and 1.8% 25ctp methylcellulose, and viewed in a JEOL 1010 or in a
Tecnai 12 (FEI) electron microscope.
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